Strain Catalog

Showing results 1901 to 2000 of 7208

< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Strain Descriptor Strain Summary Genotype Phenotype
gskA-/[act15]:GFP:tacAgskA null mutant expressing GFP-tacAaxeA2, axeB2, axeC2, gskA-, GFP:tacA, bsR, neoR
gskA-/[act15]:gskA(Y214F)gskA null mutant expressing gskA with the Zak1 phosphorylation mutation Y214FaxeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], gskA-, gskA(Y214F), bsR
gskA-/[ecmA]:LacZgskA null cells expressing lacZ under control of the ecmA promoteraxeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], gskA-[bsR-gskA], ecmA/lacZ, bsR
gskA-/[ecmB]:LacZgskA null cells expressing lacZ under control of the ecmB promoteraxeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], gskA-[bsR-gskA], ecmB/lacZ, bsR
gskA-/[unk]:pikA(1-492(S7D/S11D/S109D/S113D/S177D/S181D))PikA membrane localization domain with serine to aspartic acid substitutions at 6 potential phosphorylation sites expressed in gskA- backgroundaxeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], gskA-[bsR-gskA], pikA(1-492(S7D/S11D/S109D/S113D/S177D/S181D)), bsR, neoR
gst4-gst4 null mutant in AX2axeA2, axeB2, axeC2, gst4-, [bsRcas], bsr
GT78-FLoeHis-agtA overexpressed in AX3; neomycin resistantaxeA1, axeB1, axeC1, [His6-GT78], neoR
GT78-NoeHis-agtA (N-terminal, residues 2-310) overexpressed in AX3; neomycin resistantaxeA1, axeB1, axeC1, [His6-GT78(2-310)], neoR
gtaC-gtaC null mutantaxeA1, axeB1, axeC1, gtaC-, bsR
gtaC-gtaC null mutant in AX2axeA2, axeB2, axeC2, gtaC-, [bsR-loxP], bsR
gtaC-/[act15]:GFP:gtaCN-terminal fusion of GFP to gtaC under the control of the act15 promoter expressed in a gtaC null mutantaxeA2, axeB2, axeC2, gtaC-, [pLPBLP], [act15:GFP:gtaC], neoR
gtaC-/[act15]:GFP:gtaC(C500gtaC null mutant overexpressing GFP fused to gtaC with cysteine to serine substitutions at positiions 500,503,522,525 under the control of the act15 promoter axeA2, axeB2, axeC2, gtaC-, [pLPBLP], [act15:GFP:gtaC(C500, 503, 522, 525S)], bsR, hygR
gtaC-/[act15]:GFP:gtaC(T376A/S379gtaC null mutant overexpressing GFP fused N-terminal to gtaC with Cys to Ser substitutions at positions 500,503,522,525, and Thr/Ser residues mutated to Ala at positions 376/379/380 under the control of the act15 promoter axeA2, axeB2, axeC2, gtaC-, [pLPBLP], [act15:GFP:gtaC(T376A/S379, 380A/C500, 503, 522, 525S)], bsR, hygR
gtaC-/[act15]:gtaC:(468-496):GFP:gtaCmutant overexpressing GFP fused to the N-terminus of gtaC with the addition of an exogenous putative nuclear localization signal (NLS)axeA2, axeB2, axeC2, gtaC-, [pLPBLP], [act15:GFP:gtaC(468-496)], bsR, neoR
gtaC-KDhypomorphic mutant of gtaC: REMI insertion in the promoter of gtaC that results in >10-fold reduction in gtaC expressionaxeA1, axeB1, axeC1, gtaC-KD, bsR
gtaC-KD/[act15]:GFP:gtaChypomorphic mutant of gtaC: REMI insertion in the promoter of gtaC, expressing GFP-gtaCaxeA1, axeB1, axeC1, gtaC-KD, GFP:gtaC, bsR, neoR
gtaG-gtaG null mutant in AX4axeA1, axeB1, axeC1, gtaG-, [bsRcas], bsR
gtaG-gtaG null mutantaxeA1, axeB1, axeC1, gtaG-, [pGtaG-KO], bsR
gtaG-gtaG insertional mutant (recapituration of V10633)axeA1, axeB1, axeC1, gtaG-, [pBSR1], bsR
gtaI-gtaI insertional mutantaxeA1, axeB1, axeC1, gtaI-, [pRDR0022], bsR
gxcA-gxcA (rasGEF1) null mutantaxeA1, axeB1, axeC1, gxcA-, bsR
gxcAA-Genome Wide Dictyostelium Insertion bank (GWDI) gxcAA- mutant; insertion at position 6196058, chr 3; used enzyme: Hsp92IIaxeA1, axeB1, axeC1, gxcAA-, [bsRcas], bsR
gxcB-gxcB null mutantaxeA2, axeB2, axeC2, gxcB-, [bsR-loxP], bsR
gxcC-gxcC null mutant in AX3 backgroundaxeA1, axeB1, axeC1, gxcC-, [bsRcas], bsR
gxcC-/[act15]:GFP:gxcCgxcC null mutant overexpressing N-terminal GFP tagged gxcC under the control of the act15 promoter axeA1, axeB1, axeC1, gxcC-, [bsRcas], GFP:gxcC, [pDM317], bsR, neoR
gxcDD-gxcDD null mutantaxeA2, axeB2, axeC2, gxcDD-, bsR
gxcKK-Cheater mutant. Remi insertion in gxcKKaxeA1, axeB1, axeC1, gxcKK-, [pBSR1], bsR
gxcP-gxcP REMI mutant; the insertion site is 369 bp downstream of the start codon; insertion at the upper case NlaIII restriction site (CATG) in this sequence: gatatttCATGgaaaggg; also note that a different clone of this mutant is available (DBS0349542)
get raw sequence data
axeA1, axeB1, axeC1, gxcP-, bsR
gxcT-gxcT null cells expressed in AX2 cellsaxeA2, axeB2, axeC2, gxcT-, [bsR-loxP], bsR
gxcT-/[act15]:GFP:gxcTGFP-GxcT cells under control of act15 promotor expressed in gxcT null cellsaxeA2, axeB2, axeC2, gxcT-, [pLPBLP], GFP:gxcT, [pJK1], bsR, neoR
H3b-/H3c-H3b/H3c double null mutant in AX2axeA2, axeB2, axeC2, H3b-, [bsRcas]H3c-, [bsRcas], bsR
hatA-/[hatB]:hatBMultiple mutant containing disrupted hatA and HatB over expressed in AX2 cellsaxeA2, axeB2, axeC2, hatA-, hatB, [pDNeo2], neoR
HAZ1Wild isolate, and putative new species from Cambridgeshire, UK.wt
HB3chemosensory mutant; the parent is the cycloheximide resistant NC4 derivative DdCmat1, cyc, ts, aggaggregation defective
hbx2-hbx2 null mutant in kAX3axeA1, axeB1, axeC1, bsR, hbx2-wild type
hbx2-hbx2 null mutant in JH10axeA1, axeB1, axeC1, hbx2-wild type
hbx2-/warA-hbx2/warA- double null mutant in JH10axeA1, axeB1, axeC1, bsR, hbx2-, warA-development arrests at mound stage
hbx4-hbx4 null mutantaxeA1, axeB1, axeC1, hbx4-, [bsRcas], bsR
hbx4-/[ecmAO]:lacZhxb4 null mutant expressing lacZ under the control of the prestalk ecmAO promoteraxeA1, axeB1, axeC1, hbx4-, [bsRcas], ecmAO]:lacZ, bsR, neoR
hbx9-hbx9 null mutant in AX2axeA2, axeB2, axeC2, hbx9-, [bsRcas], bsR
hbx9-/[ecmA]:lacZhbx9 null mutant expressing LacZ under control of ecmA promotor in AX2axeA2, axeB2, axeC2, hbx9-, [bsRcas], lacZ, [pEcmA-Gal], neoR
HC112frigid mutant,fgdAtsgE13, sprA, acrA100, radE100, bwnA1, fgdA125 (formerly aggI125)agg-,brown,tsg,metR
HC198frigid mutant (fgdD)tsgE13, sprA, acrA100, radE100, bwnA1, fgdD140agg-,tsg,metR
HC213frigid mutant (fgdA)tsgE13, sprA, acrA100, radE100, bwnA1, fgdA141agg-,tsg,metR,brown
HC275frigid mutant,fgdEaxeA2, axeB2, axeC2, tsgJ2, fgdE143axe,agg-,tsg
HC317frigid mutant (fgdC)fgdC146, cycA5, bsgA5agg-
HC350agg-minus strainagg-, acrA, bwnA, cobA, tsg, man+, cyc+agg-,metR,brown,cobR,tsg
HC351agg-minus strainagg-, acrA, bwnA, tsgagg-,metR,brown,tsg
HC390control transformant for HC392axeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], ura+, [patB-KO], patB+, thy+axe,thy+
HC479ncsA+ control transformantaxeA2, axeB2, axeC2, [ncsA-KO], bsR
HC6tester strain (Rob Kay lab)axeA2, axeB2, axeC2, tsg-2(tsgJ2)axe,wt,tsg
HC6tester strain (Rich Kessin lab)axeA2, axeB2, axeC2, tsg-2(tsgJ2)axe,wt
HC91tester straintsgE13, sprA, acrA100, radE100, bwnA1, matA1wt,tsg,brown,metR,round spores
HCLaxeA1, axeB1 axeC1, hcl, neoR
hcpA-Remake of hcpA- (Heterochromatin Protein null) with bsr-cassette removed (floxed and cre''d)axeA2, axeB2, axeC2, hcpA-[hcpA-flox-cre]axe,wt
hcpA-hcpA null mutantaxeA2, axeB2, axeC2, hcpA-[hcpA-bsr], bsRaxe,bsR,wt
hcpA-/hcpB-/[act6]:GFP:hcpAGFP-hcpA overexpressed in a hcpA/hcpB double knock-out; the double null is inviable; the GFP-marked strain in a null background allows cleaner localization studiesaxeA2, axeB2, axeC2, hcpA-[hcpA-flox-cre], GFP-hcpA, hcpB-, neoR, bsR
hcpA-/[act6]:GFP:hcpAExpression of GFP-HcpA in a cre/loxP''d hcpA null mutantaxeA2, axeB2, axeC2, hcpA-[hcpA-flox-cre], GFP-hcpA, neoR
hcpA-RFPC-terminal HcpA-RFP fusion under the control of the act15 promoter expressed in wtaxeA2, axeB2, axeC2, hcpA-[hcpA-RFP], neoRaxe,neoR
hcpB-heterochromatin protein B null mutantaxeA2, axeB2, axeC2, hcpB-[pGem-hcpB-bsr], bsRaxe,bsR,wt
HD11Control cell line HD11 (for the PLC-KO HD10) is a "random" integrant of the PLC-KO vector somewhere in the genome, but not in the PLC gene, and therefore has normal PLC activity. Both HD10 and HD11 were made with G418 selection, which is known to affect PIP2 levels, thus requiring an isogenic control.axeA1, axeB1, axeC1, [pNeoPLCko], neoRaxe,wt,neoR
hdaB-attempts to produce a hdaA null mutant failedaxeA2, axeB2, axeC2, hdaB-, [bsR-loxP], bsR
HEALaxeA1, axeB1 axeC1, heal, neoR
HEBCaxeA1, axeB1 axeC1, hebc, neoR
helC-helC REMI mutanaxeA1, axeB1, axeC1, pyr5-6-[pRG24], helC-[pRH130], ura+
helC-RNA helicase null (KO)axeA1, axeB1, axeC1, pyr5-6-[pRG24], helC-[pHM444], ura+axe,loose mounds
helE-helE REMI mutantaxeA1, axeB1, axeC1, helE-, bsR
helF-Putative RNA helicase (dsRNA-binding protein) knock outaxeA2, axeB2, axeC2, helF-[helF-bsr], bsRaxe,bsR,wt
helF-GFPC-terminal HelF-GFP fusion under the control of the A15 promoteraxeA2, axeB2, axeC2, helF-GFP[helF-GFP], neoRaxe, neoR
hephA-hephA knock-out mutant in AX2axeA2, axeB2, axeC2, hephA-, [bsRcas], bsR
hfnA-cre-lox mutant of hfnA-axeA1, axeB1, axeC1, hfnA-, [loxP]
hfnA-/abpC-abpC null expressed in hfnA null backgroundaxeA1, axeB1, axeC1, hfnA-, [loxP], abpC-[pDE109], hygR
hfnA-/[ecmO]:lacZhfnA null cells expressing lacZ under the control of the pre stalk ecmO promoter axeA1, axeB1, axeC1, hfnA-, [loxP], lacZ, [pDdGal-17 (H-)], neoR
HG1694Control strain for HG1764 producing free GFP.axeA2, axeB2, axeC2, [GFP-neo], neoRaxe, neoR, gfp
HG302cAMPS-resistant mutant (aggregates and fruits in the presence of cAMPS).axeA2.axeB2.axeC2, casA1000
HG302cAMPS-resistant mutant; low ePD & ePD inhibitor; NG mutagenesis; tester strainmatA1, casA1000, axeA1, axeC1, axeB1
HG5013Chemotaxis mutant (defective in motility response to folate).axeA2, axeB2, axeC2, axe
HG5125Chemotaxis mutant (defective in motility response to folate).axeA2, axeB2, axeC2, axe
HG5142Chemotaxis mutant (defective in motility response to folate).axeA2, axeB2, axeC2, axe,agg-
hgrA-hgrA null mutant in type II congenic strainaxeA2, axeB2, axeC2, matA-, [bsRcas], matB, matC, hgrA-, [bsRcas], bsR
hgrA-/KAX3hgrA null mutant in KAX3xeA1, axeB1, axeC1, hgrA-, [bsRcas], bsR
hgrB-hgrB null mutant in type II congenic strainaxeA2, axeB2, axeC2, matA-, [bsRcas], matB, matC, hgrB-, [bsRcas], bsR
hgrB-/KAX3hgrB null mutant in KAX3axeA1, axeB1, axeC1, hgrB-, [bsRcas], bsR
HH20methanol resistant variant of NP86, an axenic V12 from Keith Williamsaxe, metaxe,metR
HH25axeA1, axeB1, axeC1, tsgaxe,wt
HH309Axenic V12 derived from a germinated macrocyst.axe, matA2axe
HH309/bsrBlasticidin-resistant version of axenic V12 derived from a germinated macrocyst.[pBSR3], bsRaxenic,bsR
HH31tester straincycA1, axeA1, axeB1, axeC1, tsgA1, bwn, cobA1brown,axe,cobR,cycR,tsg
HH31tester strain X36 selected for good growth in FM.axeA1, axeB1, axeC1, cycA1, tsgA1, bwn, cobA1axe,brown,cycR,cobR,tsg
HH31/HL16heterozygote diploid tester strain; Parents:HH31, HL16(DBS0236211) cycA5/+, stkA520/stkA501, axeA1/+, axeB1/+, tsgB1/+, cobA/+, bsgB500/+
HH31Mtester strainaxeA1, axeB1, axeC1, cycA1, tsgA1, bwn, cobA1brown,axe,cycR,cobR,tsg
HH33pyrimidine auxotrophaxeA1, axeB1, axeC1, tsg, pyr-300axe,ura-,tagg on SM
HH34pyrimidine auxotrophaxeA1, axeB1, axeC1, tsg, pyr-301axe,ura-,wt
HH36purine auxotrophaxeA1, axeB1, axeC1, tsg, pur-300axe,ade- in FM,wt
HH39purine auxotrophaxeA1, axeB1, axeC1, tsg, pur-302axe,wt,ade-
hipA+Non-homologous recombinant of the hipA gene of Dictyostelium (control strain), in AX2axeA2, axeB2, axeC2, bsRaxe, bsR
hipA+Non-homologous recombinant of the hipA gene of Dictyostelium (control strain), in DH1axeA1, axeB1, axeC1, pyr5-6-[pRG24], ura+, [pSP72-pyr-HipKO]axe
hipA-hipA null mutant in AX2axeA2, axeB2, axeC2, hipA-[pSP72BSR-HipKO], bsRaxe, bsR
hipA-Knockout of the hipA gene of Dictyostelium in DH1.axeA1, axeB1, axeC1, pyr5-6-[pRG24], ura+, hipA-[pSP72-pyr-HipKO]axe
hipA-/epnA-double knockout of hipA and epnAaxeA1, axeB1, axeC1, pyr5-6-[pRG24], ura+, hipA-, epnA-
< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Home| Contact dictyBase| SOPs| Site Map  Supported by NIH (NIGMS and NHGRI)